Asked by: Duncan Baker (Conservative - North Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people were diagnosed with (a) autism, (b) ADHD and (c) dyslexia in the East of England in the last five years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The information requested is not held centrally but may be held locally by individual National Health Service trusts or commissioners.
Asked by: Duncan Baker (Conservative - North Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support care home workers.
Answered by Gillian Keegan - Secretary of State for Education
I would like to recognise the enormous contribution care home workers, and all the care workforce, make to this country.
In our People at the Heart of Care White Paper, we set out a landmark investment of £500 million to develop and support the workforce.
This a five-fold increase in public spending on workforce training, creating hundreds of thousands of training places with clear pathways for development and progression.
These measures will make a real difference to the support that care workers get to develop and progress their career.
Asked by: Duncan Baker (Conservative - North Norfolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2021 to Question 92097 and following the Conditional Marketing Authorisation awarded by the Medicines and Healthcare products Regulatory Agency on 17 March 2022, what plans he has to ensure that severely immunocompromised patients have access to Evusheld; and what estimate he has made of when the first patients will start to receive that treatment.
Answered by Maggie Throup
We are unable to provide the information requested as it is commercially sensitive. Any public announcement on the procurement of treatments would be made after an agreement is reached with companies. The Department is scoping the potential introduction of pre-exposure prophylaxis. This includes identification of the most appropriate patient groups which could benefit and the potential deployment and administration process. However, treatments must be clinically cost-effective and demonstrate sufficient efficacy against Omicron and new variants.